April 2011
Volume 52, Issue 14
Free
ARVO Annual Meeting Abstract  |   April 2011
Mydriasis, Cataract And Glaucoma: Special Features Of Acanthamoeba Keratitis
Author Affiliations & Notes
  • Juliana F. Camargo
    Ophthalmology, UNIFESP, Sao Paulo, Brazil
  • Heloisa Nascimento
    Ophthalmology, UNIFESP, Sao Paulo, Brazil
  • Flavio E. Hirai
    Ophthalmology, Federal University of Sao Paulo, Sao Paulo, Brazil
  • Luiz Vieira
    Ophthalmology, UNIFESP, Sao Paulo, Brazil
  • Elcio Sato
    Ophthalmology, UNIFESP, Sao Paulo, Brazil
  • Fabio Ramos
    Ophthalmology, UNIFESP, Sao Paulo, Brazil
  • Annette Foronda
    Ophthalmology, UNIFESP, Sao Paulo, Brazil
  • Denise Freitas
    Ophthalmology, Federal University of Sao Paulo, Sao Paulo, Brazil
  • Footnotes
    Commercial Relationships  Juliana F. Camargo, None; Heloisa Nascimento, None; Flavio E. Hirai, None; Luiz Vieira, None; Elcio Sato, None; Fabio Ramos, None; Annette Foronda, None; Denise Freitas, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 5833. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Juliana F. Camargo, Heloisa Nascimento, Flavio E. Hirai, Luiz Vieira, Elcio Sato, Fabio Ramos, Annette Foronda, Denise Freitas; Mydriasis, Cataract And Glaucoma: Special Features Of Acanthamoeba Keratitis. Invest. Ophthalmol. Vis. Sci. 2011;52(14):5833.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Acanthamoeba causes a vision-threatening infection of the cornea, maily in contact lens wearers. In patients with corneal pseudodendrites, radial keratoneuritis and ring infiltrates, Acanthamoeba keratitis (AK) must be considered in the differential diagnosis. Clinically effective treatment of AK includes a combination of a biguanide such as chlorhexidine or polyhexanethylene biguanide (PHMB) and a diamidine such as propamidine or hexamidine. It has been suggested in the literature that cataract and iris atrophy can occur during AK treatment. The purpose of this study is to review cases of AK followed at the Department of Ophthalmology, UNIFESP, and to estimate the incidence and risk factors for the development of mydriasis, cataract and glaucoma, and associated complications.

Methods: : Case series of AK patients that were examined from 1991 to 2010. Clinical findings, risk factors, and complications were reviewed. Ocular findings after surgical treatment were also described. We collected data on visual acuity, corneal findings (ring infiltrate or radial keratoneuritis), presence of mydriasis, cataract, intraocular pressure, and indication for penetrating keratoplasty or filtering surgery.

Results: : We were able to identify 13 patients with mydriasis, cataract, and glaucoma among 370 patients with AK. All patients were soft contact lens users, except one that was a rigid contact lens user. This signs appeared after a mean of 7 months after the beginning of the symptoms. The initial visual acuity ranged from 20/25 to hand motion and de visual acuity after the surgical treatment was 20/200 or worst. In only one case the final visual acuity was 20/30. The intraocular pressure average was 29.8 mmHg before surgery. Among these 13 patients, only one presented radial keratoneuritis, all others presented ring infiltrate. All patients underwent penetrating keratoplasty, extracapsular lens extraction, intraocular lens insertion in the bag, and iridoplasty. Seven of them also had filtering surgery to intraocular pressure control.

Conclusions: : Acanhtamoeba keratitis is a sight-threatening disease and its early diagnosis is mandatory for a better prognosis. We described a new set of signs and symptoms related to AK and concluded that need of surgery was a risk factor for a poor disease prognosis.

Keywords: Acanthamoeba • contact lens • anterior segment 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×